2009
DOI: 10.1158/0008-5472.can-08-3745
|View full text |Cite
|
Sign up to set email alerts
|

NADPH Oxidase 4 Contributes to Transformation Phenotype of Melanoma Cells by Regulating G2-M Cell Cycle Progression

Abstract: Generation of reactive oxygen species (ROS) has been implicated in carcinogenic development of melanoma, but the underlying molecular mechanism has not been fully elucidated. We studied the expression and function of the superoxide-generating NADPH oxidase (Nox)4 in human melanoma cells. Nox4 was up-regulated in 13 of 20 melanoma cell lines tested. Silencing of Nox4 expression in melanoma MM-BP cells by small interfering RNAs decreased ROS production and thereby inhibited anchorage-independent cell growth and … Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

12
154
0
1

Year Published

2010
2010
2021
2021

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 167 publications
(167 citation statements)
references
References 27 publications
12
154
0
1
Order By: Relevance
“…Moreover, in the presence of DPI, intracellular ROS levels were significantly lower in K562 and HEL cells (Figure 3b). In addition, supplementary analyses showed that DPI treatment was also hindering differentiation: (1) the compound prevented the increase in cell size ( Figure 3c) and acquisition of the megakaryocytic morphological features ( Figure 3d); (2) the increase in the megakaryocytic markers (CD41 and CD61) and the decrease in the erythrocytic marker GpA were partially inhibited by DPI (Figure 3e 21 This would imply that ROS production might also be involved in cell-cycle progression, thus being crucial for endomitosis. In this sense, while this paper was in preparation, a report appeared describing the potential role of NADPH oxidases in megakaryocyte polyploidisation, 22 in agreement with our results (Figure 3f).…”
Section: Resultsmentioning
confidence: 99%
“…Moreover, in the presence of DPI, intracellular ROS levels were significantly lower in K562 and HEL cells (Figure 3b). In addition, supplementary analyses showed that DPI treatment was also hindering differentiation: (1) the compound prevented the increase in cell size ( Figure 3c) and acquisition of the megakaryocytic morphological features ( Figure 3d); (2) the increase in the megakaryocytic markers (CD41 and CD61) and the decrease in the erythrocytic marker GpA were partially inhibited by DPI (Figure 3e 21 This would imply that ROS production might also be involved in cell-cycle progression, thus being crucial for endomitosis. In this sense, while this paper was in preparation, a report appeared describing the potential role of NADPH oxidases in megakaryocyte polyploidisation, 22 in agreement with our results (Figure 3f).…”
Section: Resultsmentioning
confidence: 99%
“…This is typical for prostate cells [17][18][19][20][21][22][23][24][25], pancreatic cancer cells [26][27][28][29][30][31][32][33], melanoma cells [34][35], breast cancer cells [36][37][38][39], and other cancer cells [40][41][42][43][44][45][46][47][48][49][50]. It is important that the elevated ROS formation in cancer cells can have both surviving and hindering effects.…”
Section: Cancermentioning
confidence: 99%
“…Overproduction of intracellular ROS has been considered as a risk factor in cancer development. In this context it should be noted that aberrant activation of the Nox activity benefits transformation phenotypes of a subset of cancer cells (2); that is, Nox1 in Rastransformed cells (3), Nox4 in pancreatic cancer (4) and melanoma cells (5), and Nox5 in esophageal adenocarcinoma cells (6). With regard to Nox1, Ras oncogene up-regulated the Nox1 expression by activating GATA-6 through mitogen-activated extracellular signal-regulated kinase (MEK)-extracellular signal-regulated kinase (ERK)-dependent phosphorylation (7).…”
mentioning
confidence: 99%